Partnership Enhances Genetic Testing in Turkey
Muhdo Health, a prominent name in the field of DNA and Epigenetic consumer testing, has embarked on an exciting journey by forming an exclusive distribution partnership with Rgentic Saglik Turizm ve Ticaret AS. This collaboration heralds a new chapter for Muhdo, allowing them to offer their innovative genetic testing kits to the Turkish market.
Local Language Support for Enhanced Accessibility
In a bid to provide a seamless customer experience, the Muhdo Health app will now be available in Turkish. This makes it easier for local consumers to access and understand their genetic testing results right on their mobile devices. Additionally, a dedicated Turkish-language version of the Muhdo web-based Practitioner Portal will facilitate consultations for local clinics, enhancing service delivery in the healthcare sector.
A Dedicated Online Presence for Turkish Consumers
Rgentic is set to launch a dedicated Muhdo-branded website, specifically tailored for the Turkish audience, which will provide access to a variety of DNA and Epigenetic testing options. This online resource aims to cater to the needs of Turkish consumers and clinics, ensuring that the partnership is well-supported.
Opportunities for Growth in the Health Sector
This exclusive distribution arrangement is a significant milestone for Muhdo, presenting ample opportunities for establishing a robust presence in Turkey's thriving health and longevity sector. According to Nathan Berkley, CEO of Muhdo Health, the partnership aims to enhance brand visibility in Turkey while tapping into a market renowned for its focus on health and wellness.
Leadership Perspectives on the Partnership
Nathan Berkley remarked on the importance of partnering with Rgentic, a trusted entity with strong commercial connections. He believes this collaboration will help Muhdo reach a broader audience, promoting healthier lifestyles and longevity in Turkey.
About Rgentic and Its Vision
Tekin Aldemir, Director at Rgentic, expressed excitement about the partnership, emphasizing their commitment to providing clients with top-notch genetic and epigenetic testing solutions. Aldemir envisions further collaboration that could extend beyond Turkey, utilizing Rgentic's established network in neighboring regions.
About Muhdo: Innovating Wellness Through Genetics
Muhdo Health is distinguished as the pioneer in offering a comprehensive epigenetic profiling program tailored for both consumers and businesses. Their mission is to inspire healthier, happier, and longer lives through personalized health solutions. With a vision centered around preventive healthcare and advanced analytics, Muhdo is set to transform how wellness is perceived and achieved.
Frequently Asked Questions
What is the main goal of the Muhdo and Rgentic partnership?
The partnership aims to enhance the accessibility of genetic testing services in Turkey and support local healthcare providers and consumers.
How will Muhdo support Turkish consumers in understanding their results?
Muhdo will offer its app and Practitioner Portal in Turkish, making it easier for users to interpret their genetic testing outcomes.
What types of services will the new Muhdo website provide?
The dedicated website will feature various DNA and Epigenetic tests tailored to the needs of Turkish consumers.
Who are the key leaders involved in this partnership?
Nathan Berkley, CEO of Muhdo Health, and Tekin Aldemir, Director of Rgentic, have been pivotal in establishing this collaboration.
What is unique about Muhdo's approach to health and wellness?
Muhdo is focused on the mass personalization of health through epigenetics, offering a comprehensive approach to preventive health and well-being.
